Risperidone versus haloperidol in the treatment of schizophrenia: a meta‐analysis comparing their efficacy and safety

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 21, Iss. 5, 1996-10 ,pp. : 349-358

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings

By Mladsi Deirdre M.   Grogg Amy L.   Irish William D.   Lopez Rebecca B.   Degen Kathleen   Swann Alan   Nimsch Christian T.  

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 1883-1893

Informa Healthcare

Access to resources Recommend Favorite

A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany

By Beard Stephen   Maciver Fiona   Clouth Johannes   Rüther Eckart  

The European Journal of Health Economics, Vol. 7, Iss. 3, 2006-09 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

Leukopenia Associated with Risperidone Treatment

By  

Current Drug Safety, Vol. 12, Iss. 2, 2017-07 ,pp. : 126-130

Bentham Science Publishers

Access to resources Recommend Favorite

Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia

By Ascher-Svanum Haya   Stensland Michael D.   Peng Xiaomei   Faries Douglas E.   Stauffer Virginia L.   Osuntokun Olawale O.   Kane John M.  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 115-122

Informa Healthcare

Access to resources Recommend Favorite